JPRN-jRCT1060220042
Recruiting
未知
Feasibility study of postoperative adjuvant therapy using S-1 (Tegafur/Gimeracil/Oteracil Potassium) after curative esophagectomy for esophageal cancer
Hirahara Noriyuki0 sites45 target enrollmentJuly 9, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hirahara Noriyuki
- Enrollment
- 45
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Histologically confirmed esophageal squamous cell carcinoma or adenocarcinoma.
- •2\) Postoperative adjuvant chemotherap using S\-a was performed.
- •3\) Curative gastrectomy was performed.
- •4\) Performance status of 0\-1 on the Eastern Cooperative Oncology Group classification
- •5\) No prior chemotherapy, radiation, endcrine, molecular targeted therapy within 5 years including treatment for other cancers,
- •6\) Sufficient oral intake.
Exclusion Criteria
- •(1\)Double cancer
- •(2\)Heart failure, hepatitis, renal dysfunction
- •(3\)Severe infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A feasibility study of postroperative adjuvant chemotherapy using platinum-based chemotherapy followed by maintenance TS-1 for completely resected pathologic stage II-IIIA non-small cell lung cancer with a biomarker study of circulating tumor cellCompletely resected pathologic stage II-IIIA non-small cell lung cancerJPRN-UMIN000002592DEPARTMENT OF THORACIC SURGERY, HYOGO COLLEGE OF MEDICINE40
Completed
Not Applicable
Feasibility study of a postoperative adjuvant chemotherapy which performs the maintenance therapy of TS-1 after CBDCA+TS-1 to the patients of pathological stage II-IIIA with completely resected non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000006351Escargot40
Completed
Not Applicable
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50
Completed
Phase 1
Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer.Pancreatic cancerJPRN-UMIN000004332Tokyo Women's Medical University20
Completed
Phase 4
Evaluation of Effects of Postoperative Adjuvant Therapy with Anastrozole on Bone in Postmenopausal Women with Breast CancerHormone-responsive postmenopausal breast cancerJPRN-UMIN000000514Saitama Breast Cancer Clinical Study Group (SBCCSG)350